• Senate Reintroduction of the Cardiomyopathy Health, Education, Awareness, Risk Assessment, and Training in the Schools Act- HEART ACT(H.R. 4015); Cardiomyopathy Research Issues; Health Professional and Public Cardiomyopathy Education and Awareness Issues; Safe Play Act (S. 436/H.R. 829); reintroduction of Teaching Children to Save Lives Act.
• House and Senate Labor, Health and Human Services, Education and Related Agencies FY 2016 Appropriations pertaining to cardiomyopathy research and medical, education and awareness efforts (H.R. 3020/S.1695); Consolidated appropriations Package (H.R. 2029).
• Incorporation of Safe Play Act language into S. 1177 - Every Child Achieves Act of 2015.

Duration: October 1, 2011 to December 31, 2015

General Issues: Medical/Disease Research/Clinical Labs, Budget/Appropriations, Education

Spending: about $360,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2011: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Natl Institutes of Health (NIH),, Health & Human Services - Dept of (HHS), U.S. Senate,, Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC),